Childhood-Onset ANCA-Associated Vasculitis: From Genetic Studies to Advances in Pathogenesis, Classification and Novel Therapeutic Approaches
2024

Childhood-Onset ANCA-Associated Vasculitis: Understanding and Managing the Disease

Sample size: 406 publication Evidence: moderate

Author Information

Author(s): Yeo Liching, Naheed Asma, Richards Chantelle, Ciurtin Coziana, Torras-Ambròs Joan

Primary Institution: University College London

Conclusion

Childhood-onset ANCA-associated vasculitis is rare but poses significant challenges in diagnosis and management, with a need for improved understanding and treatment strategies.

Supporting Evidence

  • Childhood AAV has a higher female preponderance compared to adults.
  • The median age of diagnosis for childhood AAV is between 10.7 and 14 years.
  • 65% of children with AAV present with renal involvement.
  • 40% of children with ANCA-associated glomerulonephritis required kidney replacement therapy after a median of 26 months post-diagnosis.
  • Only 42% of children with AAV achieved remission despite treatment.

Takeaway

This study talks about a rare disease that affects kids' blood vessels and how doctors are trying to understand and treat it better.

Methodology

This review summarizes existing literature on childhood-onset ANCA-associated vasculitis, focusing on clinical presentation, genetic studies, and management strategies.

Limitations

The review is limited by the scarcity of data on pediatric AAV compared to adult cases.

Participant Demographics

The study includes data from 406 children with ANCA-associated vasculitis, with a noted higher female preponderance.

Statistical Information

Confidence Interval

95% CI, 1.1–5.4

Digital Object Identifier (DOI)

10.3390/ijms252413704

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication